CD274 and small cell lung carcinoma: Thus, in this comparative retrospective study, we determined the concordance rate of PD-L1 expression between EBUS-TBNA and matched TBB specimens obtained from the same patient (with stage III/IV NSCLC or SCLC) using the 22C3 anti-PD-L1 antibody.